How is Syn-Ake used?

Strengths and schedules in the sources
SourceDose and schedulePeopleLength
Maker's brochure, suggested use1-4% in finished products, no schedule stated1Not statedNot stated
Maker's brochure, cream test4% cream on the forehead, twice daily, against placebo115 per group, aged 40-6028 days
Maker's page, cream test4% cream, twice daily, against placebo2100 volunteers, 25 per group4 weeks
Zhu and colleagues (2026), five-active serum2% Syn-Ake and 2% of a second peptide, twice a day on the whole face350 (study 1) and 42 (study 2), single-arm, Chinese female participantsUp to 12 weeks in study 1; up to 8 weeks in study 2

The maker suggests 1-4% Syn-Ake, a preservative-free, glycerine-based aqueous solution supplied only to businesses, in a finished cosmetic product for the skin, and its 4% cream tests applied it twice daily for 4 weeks.12

Strengths and schedules in the sources

The table is set at the top of the page

The maker's two descriptions of its 4% cream test differ in size, at 15 volunteers per group in the brochure and 100 volunteers, 25 per group, on the page; both give the same length, 28 days in the brochure and 4 weeks on the page.12 The 2026 studies by Zhu and colleagues (50 and 42 participants) were single-arm and enrolled Chinese female participants, and the serum has five active ingredients, so it is a combination product, not Syn-Ake alone.3 Apart from the maker's own 4% cream tests and the serum paper's combination product, the search found no human trial of Syn-Ake alone.123

Supply, route, mixing and syringe units

The maker describes Syn-Ake as a preservative-free, glycerine-based aqueous solution, and says it supplies only to businesses.2 The brochure presents it as an ingredient for wrinkle-smoothing products, and the serum paper calls it a snake venom-mimicking peptide.13 The sources apply it to the skin: the forehead in the brochure test, and the entire face including the eye area in the serum study.13

A search of the maker's pages, DailyMed and PubMed found no reconstitution instructions or water volume, and no mg/mL concentration or U-100 syringe use. With no strength in mg/mL stated, there is no dose to convert; how units work for injectables is in units and dosing.

Storage

A search of the maker's brochure and page found no storage statement; the page offers a Safety Data Sheet download, which was not fetched.2

Frequently asked questions

Is there a drug label or registered trial for Syn-Ake?

A search of DailyMed and ClinicalTrials.gov found no label and no registered study for Syn-Ake.

What safety information do the sources state?

The 2026 serum paper by Zhu and colleagues reports no adverse events in any of its clinical studies, which tested the five-active serum, not Syn-Ake alone.3 The maker's page calls it safe for topical applications.2 The paper also says published research on its anti-wrinkle effects is limited.3

References

  1. DSM. SYN®-Peptides. dsm.com
  2. dsm-firmenich. SYN-AKE®. dsm-firmenich.com
  3. PubMed. The effect of a serum containing acetyl hexapeptide‐8, dipeptide diaminobutyroyl benzylamide diacetate and gluconolactone on skin biomarkers, wrinkles and skin texture: Ex vivo and clinical studies. 2026. pmc.ncbi.nlm.nih.gov